Psychotropic drugs as inhibitors of glycerolipid biosynthesis and secretion in primary rat hepatocyte cultures

Toxicology in Vitro : an International Journal Published in Association with BIBRA
U A BoelsterliP Donatsch

Abstract

Glycerolipid synthesis and secretion in rat hepatocyte monolayer cultures have been studied as possible endpoints in cytotoxicity assays. Ten psychotropic drugs of different structural classes were incubated with the hepatocytes at concentrations ranging from 10(-6)m to 5 x 10(-5)m and their effects on the incorporation of [(3)H]glycerol into glycerolipids and on the subsequent lipid secretion into the medium were measured. After 2-hr exposures to eight of the ten drugs, glycerolipid secretion was inhibited as a function of the drug concentration. The integrity of the plasma membrane, however, was still preserved, as no leakage of the cytosolic enzyme, lactate dehydrogenase, occurred. The incorporation of [(3)H]glycerol into the total cell-associated glycerolipid fraction was much less affected by the drugs than was the medium-associated fraction. In this model, the tricyclic antidepressants, imipramine, clomipramine and amitriptyline caused a marked inhibition of in vitro glycerolipid secretion. Chlorpromazine, thioridazine, fluperlapine, haloperidol and promazine were of intermediate potency, and clozapine and sulpiride had no inhibitory effect on glycerolipid secretion. A significant inhibition of glycerolipid secretion was ...Continue Reading

References

Nov 1, 1975·CRC Critical Reviews in Toxicology·H LüllmannO Wassermann
Apr 1, 1976·The Journal of Pharmacy and Pharmacology·R H MichellD N Brindley
Oct 27, 1975·Biochemical and Biophysical Research Communications·K N JeejeebhoyJ Jeejeebhoy
Nov 15, 1976·Experientia·D A Young
Jan 1, 1979·Toxicology and Applied Pharmacology·H YasuharaK Arakawa
Jan 1, 1977·Biochemical Society Transactions·D N BrindleyJ Cooling
Sep 1, 1977·Proceedings of the Society for Experimental Biology and Medicine·C O AbernathyH J Zimmerman
Feb 1, 1975·Biochemical Pharmacology·C O AbernathyH J Zimmerman
Sep 1, 1987·Cell Biology and Toxicology·U A BoelsterliP Donatsch
Jul 1, 1985·Toxicology and Applied Pharmacology·H YasuharaK Sakamoto
Jan 1, 1980·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·J J HauwN Baumann
Jun 1, 1984·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·F GoethalsM Roberfroid
Feb 15, 1982·Biochemical Pharmacology·S C TsaoM Hanano
Jan 1, 1981·Journal of Toxicology and Environmental Health·D B Mitchell, D Acosta

❮ Previous
Next ❯

Citations

Sep 1, 1987·Cell Biology and Toxicology·U A BoelsterliP Donatsch
Jun 1, 1997·Journal of Helminthology·Z Borosková, E Dvoroznáková

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.